Search

everythinglearnresearchcommunity

for

Search:↓

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Janus kinase inhibitors show promise for treating alopecia areata in children.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Higher IgE levels may play a role in alopecia areata, especially in males, children, and severe cases.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

People with alopecia areata may have a higher risk of blood clots.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Fzd2 is important for skin and hair development through various signaling ways.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

RXRα is crucial for proper immune response and links diet to immune function.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

Regulatory T cells are essential for normal and improved wound healing in mice.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.